Tvardi Therapeutics (TVRD) Receivables - Other: 2015-2017
Historic Receivables - Other for Tvardi Therapeutics (TVRD) over the last 2 years, with Sep 2017 value amounting to $97,000.
- Tvardi Therapeutics' Receivables - Other fell 15.65% to $97,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $97,000, marking a year-over-year decrease of 15.65%. This contributed to the annual value of $87,000 for FY2016, which is 8.75% up from last year.
- Tvardi Therapeutics' Receivables - Other amounted to $97,000 in Q3 2017, which was down 44.57% from $175,000 recorded in Q2 2017.
- Tvardi Therapeutics' Receivables - Other's 5-year high stood at $2.1 million during Q3 2015, with a 5-year trough of $80,000 in Q4 2015.
- Its 3-year average for Receivables - Other is $464,667, with a median of $128,000 in 2016.
- In the last 5 years, Tvardi Therapeutics' Receivables - Other plummeted by 94.63% in 2016 and then skyrocketed by 668.75% in 2017.
- Over the past 3 years, Tvardi Therapeutics' Receivables - Other (Quarterly) stood at $80,000 in 2015, then rose by 8.75% to $87,000 in 2016, then dropped by 15.65% to $97,000 in 2017.
- Its Receivables - Other stands at $97,000 for Q3 2017, versus $175,000 for Q2 2017 and $984,000 for Q1 2017.